Frontlight ResearchEarly access
Gaucher disease trials in United States
3 of 17 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Gaucher Disease Gene Therapy Trial With FLT201
- Where
- Atlanta, Aurora, Cincinnati, Dallas, Durham, Fairfax, Hackensack, Iowa City, Los Angeles, Minneapolis, New York, Philadelphia, Pittsburgh, San Francisco
- Age
- 18 years and over
- People
- 45 worldwide
- Run by
- Spur Therapeutics
See details and how to joinNCT07223944 · EU 2025-520765-50-00 - Phase 1Taking peoplePEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
- Where
- San Francisco
- Age
- 18 years to 50 years
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT04532047 - Phase 2Taking peopleReduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- Where
- Pittsburgh
- Age
- 2 months to 55 years
- People
- 100
- Run by
- Paul Szabolcs
See details and how to joinNCT01962415